Antifungal stewardship in critically ill patients
Document type :
Article dans une revue scientifique
Permalink :
Title :
Antifungal stewardship in critically ill patients
Author(s) :
De Pascale, Gennaro [Auteur]
Università cattolica del Sacro Cuore = Catholic University of the Sacred Heart [Roma] [Unicatt]
Martin-Loeches, Ignacio [Auteur]
Nseir, Saad [Auteur]
Unité de Glycobiologie Structurale et Fonctionnelle (UGSF) - UMR 8576
Università cattolica del Sacro Cuore = Catholic University of the Sacred Heart [Roma] [Unicatt]
Martin-Loeches, Ignacio [Auteur]
Nseir, Saad [Auteur]
Unité de Glycobiologie Structurale et Fonctionnelle (UGSF) - UMR 8576
Journal title :
Intensive Care Medicine
Abbreviated title :
Intensive Care Med
Volume number :
49
Pages :
681-684
Publisher :
Springer Science and Business Media LLC
Publication date :
2023-03-24
ISSN :
0342-4642
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
In critically ill patients, empirical antifungal treatment is commonly used because of poor prognosis of these infections, especially when initial antifungal treatment is inappropriate or delayed. In addition, accuracy of ...
Show more >In critically ill patients, empirical antifungal treatment is commonly used because of poor prognosis of these infections, especially when initial antifungal treatment is inappropriate or delayed. In addition, accuracy of available diagnostic tools is limited. However, excessive use of antifungals is potentially associated with side-effects, higher cost and emergence of pathogenic fungi. We aim to provide a short summary of recent data on invasive fungal infections management to improve antifungal use in critically ill patients.Show less >
Show more >In critically ill patients, empirical antifungal treatment is commonly used because of poor prognosis of these infections, especially when initial antifungal treatment is inappropriate or delayed. In addition, accuracy of available diagnostic tools is limited. However, excessive use of antifungals is potentially associated with side-effects, higher cost and emergence of pathogenic fungi. We aim to provide a short summary of recent data on invasive fungal infections management to improve antifungal use in critically ill patients.Show less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Université de Lille
CNRS
CNRS
Research team(s) :
Glycobiology in fungal Pathogenesis and Clinical Applications
Submission date :
2024-03-01T09:37:42Z
2024-03-01T10:16:08Z
2024-03-01T10:16:08Z
Files
- P23.49 s00134-023-07034-7.pdf
- Version éditeur
- Restricted access
- Access the document